-+ 0.00%
-+ 0.00%
-+ 0.00%

Pliant Therapeutics directors Pyott, Knobil, Bruhn to retire at annual meeting

PUBT·04/17/2026 20:32:28
Listen to the news
Pliant Therapeutics directors Pyott, Knobil, Bruhn to retire at annual meeting
  • Pliant Therapeutics disclosed planned board departures tied to 2026 annual meeting.
  • David E.I. Pyott, Class I director, will retire from board effective at annual meeting.
  • Katharine Knobil, Class II director, will retire from board effective at annual meeting.
  • Suzanne Bruhn, Class III director, will not stand for reelection, exiting board at annual meeting.
  • Company said departures were not related to disagreements over operations, policies, or practices.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pliant Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001746473-26-000050), on April 17, 2026, and is solely responsible for the information contained therein.